PR Newswire

Cision is a leading global provider of earned media software. Cision PR Newswire empowers communicators to identify influencers, craft campaigns and attribute value from the broadest spectrum of media sources, allowing them to create meaningful stories and measure the impact.
Results: 9601-9612 of 37078

Rolling sBLA initiated to the U.S. FDA for Leqembi® Iqlik™ (lecanemab-irmb) as a subcutaneous starting dose for the treatment of early Alzheimer's disease under Fast Track status








